31.07.2008 20:05:00
|
Dolby Laboratories Reports Third Quarter Fiscal 2008 Results
Dolby Laboratories, Inc. (NYSE:DLB) today announced the Company's
financial results for its third quarter of fiscal 2008.
For the third quarter, Dolby reported total revenue of $154.3 million,
compared to $119.6 million for the third quarter of fiscal 2007, an
increase of 29 percent. Third quarter net income was $46.4 million, or
$0.40 per diluted share, compared to $29.7 million, or $0.26 per diluted
share, for the third quarter of fiscal 2007.
Net income for the third quarter of fiscal 2008 reflects stock-based
compensation expense of $5.6 million compared to $5.1 million for the
third quarter of fiscal 2007. Net income for the third quarter of fiscal
2008 also reflects charges related to the amortization of intangibles of
$3.0 million compared to $1.0 million for the third quarter of fiscal
2007.
"During the quarter, we experienced strong financial results while
continuing to make progress in key initiatives such as PC Entertainment
Experience and Dolby Mobile,” said Bill
Jasper, President and Chief Executive Officer, Dolby Laboratories. "Earlier
this week, LG, a global technology and design leader in mobile
communications, announced it would introduce high-end multimedia
handsets with Dolby Mobile by the end of calendar year 2008.” Guidance
Dolby now expects fiscal 2008 revenue to be $605 million to $625
million. Net income for fiscal 2008 is now expected to be $181 million
to $190 million. Earnings per diluted share is now expected to be $1.57
to $1.65. While under FAS 123R, stock-based compensation expense may
vary based on factors such as stock price or volatility, Dolby now
expects stock-based compensation expense for fiscal 2008 to be
approximately $23 million. In addition, Dolby continues to expect
charges related to the amortization of intangibles for fiscal 2008 to be
approximately $13 million.
The Company's Conference Call Information
Members of Dolby management will lead a conference call open to all
interested parties to discuss Dolby Laboratories’
Q3 fiscal 2008 financial results at 2:00 p.m. PT/5:00 p.m. ET, Thursday,
July 31, 2008.
Access to the teleconference will be available over the Internet from http://investor.dolby.com/medialist.cfm
or by dialing 1-888-228-5281. International callers can access the
conference call at 1-913-312-1423.
A replay of the call will be available beginning at 5:00 p.m. PT on July
31, 2008 until 9:00 p.m. PT on August 7, 2008; dial 1-888-203-1112
(international callers can access the replay by dialing 1-719-457-0820)
and enter confirmation code 8298423. An archived version of the
teleconference will also be available on Dolby Laboratories’
website, www.dolby.com.
Forward-Looking Statements
Certain statements in this press release, including statements relating
to Dolby's expectations regarding revenue, net income, earnings per
diluted share, stock-based compensation expense, and charges relating to
the amortization of intangibles, for the fiscal year ending September
26, 2008, Dolby’s continued progress on key
initiatives such as PC Entertainment Experience and Dolby®
Mobile, and the timing and availability of LG handsets with Dolby Mobile
are "forward-looking statements”
that are subject to risks and uncertainties. These forward-looking
statements are based on management’s current
expectations, and as a result of certain risks and uncertainties actual
results may differ materially from those projected. The following
important factors, without limitation, could cause actual results to
differ materially from those in the forward-looking statements: risks
associated with trends in the markets in which Dolby operates, including
trends related to DVD and Blu-ray™ DVD,
broadcast, personal computer, gaming, mobile, or portable device
markets, and trends relating to the development of additional and newer
markets for Dolby technologies; the timing and effects of economic
downturns in the United States and abroad; pricing pressures; the risk
that LG may not ship handsets with Dolby Mobile by calendar year end or
at all; the timing of Dolby's receipt of royalty reports and/or payments
from its licensees; Dolby’s accuracy of
calculation of royalties due to its licensors; Dolby’s
ability to develop, maintain, and strengthen relationships with industry
participants; Dolby’s ability to develop and
deliver innovative technologies in response to new and growing markets
in the entertainment industry; competitive risks; risks associated with
conducting business in China and other countries, including countries
that have historically limited recognition and enforcement of
intellectual property and contractual rights; risks associated with the
motion picture industry generally; the development and growth of the
market for digital cinema and digital 3D and Dolby’s
ability to successfully penetrate this market; Dolby’s
ability to expand its business generally, and to expand its business
beyond sound technologies to other technologies related to digital
entertainment delivery, including by acquiring and successfully
integrating businesses or technologies; and other risks detailed in Dolby’s
Securities and Exchange Commission filings and reports, including the
risks identified under the section captioned "Risk
Factors” in its most recent Quarterly Report
on Form 10-Q. Dolby disclaims any obligation to update information
contained in these forward-looking statements whether as a result of new
information, future events, or otherwise.
About Dolby Laboratories
Dolby Laboratories (NYSE: DLB) is the global leader in technologies that
are essential elements in the best entertainment experiences. Founded in
1965 and best known for high-quality audio and surround sound, Dolby
innovations enrich entertainment at the movies, at home, or on the go.
Visit www.dolby.com for more
information.
Dolby and the double-D symbol are registered trademarks of Dolby
Laboratories. S08/20185 DLB-F
DOLBY LABORATORIES, INC. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
Fiscal Quarter Ended Fiscal Year-to-Date Ended June 29, 2007 June 27, 2008 June 29, 2007 June 27, 2008 (unaudited) (in thousands, except per share amounts)
Revenue:
Licensing
$
94,795
$
127,558
$
283,812
$
399,607
Product sales
17,191
18,060
47,870
53,698
Services
7,627
8,699
21,383
23,796
Total revenue
119,613
154,317
353,065
477,101
Cost of revenue:
Cost of licensing
8,478
3,361
26,287
12,179
Cost of product sales(1)
8,119
9,461
24,519
29,649
Cost of services(1)
2,963
3,194
8,470
9,400
Total cost of revenue
19,560
16,016
59,276
51,228
Gross margin
100,053
138,301
293,789
425,873
Operating expenses:
Selling, general and administrative(1)
48,430
54,979
128,266
161,275
Research and development(1)
11,854
15,366
31,650
44,998
Gain on settlements
(350
)
(250
)
(1,850
)
(499
)
Total operating expenses
59,934
70,095
158,066
205,774
Operating income
40,119
68,206
135,723
220,099
Other income, net
5,759
2,661
17,118
10,269
Income before provision for income taxes and controlling interest
45,878
70,867
152,841
230,368
Provision for income taxes
(15,839
)
(24,117
)
(53,067
)
(78,516
)
Income before controlling interest
30,039
46,750
99,774
151,852
Controlling interest in net income, net of tax
(354
)
(302
)
(1,101
)
(953
)
Net income $ 29,685
$ 46,448
$ 98,673
$ 150,899
Basic earnings per share
$
0.27
$
0.42
$
0.91
$
1.36
Diluted earnings per share
$
0.26
$
0.40
$
0.87
$
1.32
Weighted-average shares outstanding (basic)
109,692
111,844
108,898
111,209
Weighted-average shares outstanding (diluted)
113,696
114,875
113,389
114,672
(1) Stock-based compensation included above was classified as
follows:
Cost of product sales
$
269
$
167
$
679
$
670
Cost of services
39
48
107
126
Selling, general and administrative
3,838
4,262
11,459
13,157
Research and development
993
1,158
2,512
3,277
DOLBY LABORATORIES, INC. CONDENSED CONSOLIDATED BALANCE SHEETS
September 28, 2007 June 27, 2008 (unaudited)(in thousands) ASSETS
Current assets:
Cash and cash equivalents
$
368,467
$
369,907
Short-term investments
231,217
49,552
Accounts receivable, net
28,165
45,933
Inventories
14,883
22,000
Deferred income taxes
73,686
85,576
Prepaid expenses and other current assets
17,000
47,018
Total current assets
733,418
619,986
Property, plant and equipment, net
85,552
85,775
Intangible assets, net
35,389
90,751
Goodwill
39,364
273,552
Long-term investments
73,224
179,538
Long-term deferred income taxes
12,393
12,817
Other assets
12,357
13,188
Total assets $ 991,697 $ 1,275,607
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable and accrued liabilities
$
119,068
$
143,312
Income taxes payable
9,051
2,833
Current portion of long-term debt
1,563
1,607
Deferred revenue
13,522
30,894
Total current liabilities
143,204
178,646
Long-term debt
9,691
8,408
Long-term deferred revenue
5,073
6,069
Deferred income tax liability
-
18,985
Other non-current liabilities
14,294
29,323
Total liabilities
172,262
241,431
Controlling interest
22,279
22,699
Stockholders' equity:
Class A common stock
49
52
Class B common stock
61
61
Additional paid-in capital
375,830
424,502
Retained earnings
409,749
560,936
Accumulated other comprehensive income
11,467
25,926
Total stockholders' equity
797,156
1,011,477
Total liabilities and stockholders' equity $ 991,697 $ 1,275,607
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Dolby Laboratories Inc.mehr Nachrichten
18.11.24 |
Ausblick: Dolby Laboratories präsentiert Quartalsergebnisse (finanzen.net) | |
04.11.24 |
Erste Schätzungen: Dolby Laboratories stellt Ergebnisse des abgelaufenen Quartals vor (finanzen.net) | |
06.08.24 |
Ausblick: Dolby Laboratories verkündet Quartalsergebnis zum jüngsten Jahresviertel (finanzen.net) | |
23.07.24 |
Erste Schätzungen: Dolby Laboratories stellt Ergebnisse des abgelaufenen Quartals vor (finanzen.net) |